Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Anibal Drelichman

Oncology | Hematology

Newland Medical Associates, P.C.

5701 Bow Pointe Dr, Suite 335,

Clarkston, MI

Clinical Trials:Currently Recruiting for 1 Trial

Accepting New Patients

Experienced in WT1-Related Wilms Tumor Syndromes

Newland Medical Associates, P.C.

5701 Bow Pointe Dr, Suite 335,

Clarkston, MI

OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Anibal Drelichman is an Oncologist and a Hematologist in Clarkston, Michigan. Dr. Drelichman is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, and Familial Colorectal Cancer. Dr. Drelichman is currently accepting new patients.

His clinical research consists of participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Oncology

Hematology

Licenses

Internal Medicine in MI

Hospital Affiliations

Ascension St John Hospital

Ascension Providence Rochester Hospital

Languages Spoken

English

Portuguese

Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance

Find your insuranceClose

Accepted insurance plans:

Aetna

Anthem

Blue Cross Blue Shield

CareFirst

Cigna

Health Alliance Plan

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE SNP
MEDICARE-MEDICAID PLAN
OTHER COMMERCIAL
OTHER MEDICARE
OTHER MEDICARE PART D

Health Care Services Corporation

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
OTHER COMMERCIAL
OTHER MEDICARE
OTHER MEDICARE PART D
PPO

Humana

HMO
INDEMNITY
POS
PPO

Managed Medicaid

OTHER MANAGED MEDICAID

McLaren Health

Medicaid

OTHER MEDICAID
STATE MEDICAID

Meridian Choice

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE SNP
MEDICARE-MEDICAID PLAN
OTHER COMMERCIAL
OTHER MEDICARE
OTHER MEDICARE PART D

Spectrum Priority Health

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
OTHER COMMERCIAL

UnitedHealthcare

Wellcare

EPO
HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
MEDICARE-MEDICAID PLAN
OTHER MEDICARE
OTHER MEDICARE PART D

View 10 Less Insurance Carriers -

Locations

NEWLAND MEDICAL ASSOCIATES, P.C.
5701 Bow Pointe Dr, Suite 335, Clarkston, MI 48346

Call: 248-707-3132

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation

Enrollment Status: Recruiting

Publish Date: August 20, 2025

Intervention Type: Other, Biological, Drug

Study Drugs: Bortezomib, Daratumumab and Hyaluronidase-fihj, Dexamethasone, Lenalidomide

Study Phase: Phase 3

PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]